AI assistant
Sending…
COMMERCE BANCSHARES INC /MO/ — Director's Dealing 2011
Jan 19, 2011
30742_dirs_2011-01-19_8a3894b2-67c8-4c75-820e-183eb3cc1906.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: COMMERCE BANCSHARES INC /MO/ (CBSH)
CIK: 0000022356
Period of Report: 2011-01-18
Reporting Person: KEMPER DAVID W (Director, Chairman of the Board, CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-01-18 | Common Stock | M | 113905 | $35.1915 | Acquired | 1251196 | Direct |
| 2011-01-18 | Common Stock | F | 94118 | $42.59 | Disposed | 1157078 | Direct |
| 2011-01-18 | Common Stock | F | 5303 | $42.59 | Disposed | 1151775 | Direct |
| 2011-01-19 | Common Stock | S | 14484 | $42.3989 | Disposed | 1137291 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-01-18 | Non-qualified Stock Option (Right to Buy) | $35.1915 | M | 113905 | Disposed | 2015-01-28 | Common Stock (113905) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 4565 | Indirect |
| Common Stock | 12751 | Indirect |
| Common Stock | 12750 | Indirect |
| Common Stock | 12751 | Indirect |
| Common Stock | 12750 | Indirect |
| Common Stock | 9165 | Indirect |
| Common Stock | 25357 | Indirect |
| Common Stock | 53462 | Indirect |
| Common Stock | 192345 | Indirect |
| Common Stock | 25487 | Indirect |
Footnotes
F1: Sale price range is $42.2616 to $42.5700 per share.
More from COMMERCE BANCSHARES INC /MO/
Regulatory Filings
2026
May 12
Major Shareholding Notification
2026
May 12
Regulatory Filings
2026
May 11
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 27
Regulatory Filings
2026
Apr 21
Regulatory Filings
2026
Mar 30